• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TRIVIDIA HEALTH INC TRUE METRIX PRO; SYSTEM, TEST BLOOD GLUCOSE, OVER THE COUNTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TRIVIDIA HEALTH INC TRUE METRIX PRO; SYSTEM, TEST BLOOD GLUCOSE, OVER THE COUNTER Back to Search Results
Model Number STRIP, TRUE METRIX PRO50CT MG/DL
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/17/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Internal report reference number: (b)(4).Meter and test strips were not returned for evaluation.Added most likely underlying root cause onto case as the complaint product was not returned for investigation.Most likely underlying root cause: mlc-062: user had poor technique note: manufacturer contacted customer in a follow-up call on 23-jan-2023 to ensure the replacement products resolved the initial concern - able to establish contact with customer who stated replacement products resolved initial concern.
 
Event or Problem Description
Consumer reported complaint for high and erratic blood glucose test results.Caregiver is calling on behalf of the customer.The customer is concerned with test results from results obtained of 158, 157, 210, 189 and 568 mg/dl.The customer¿s expected blood glucose test result ranges are 80-130 mg/dl am fasting and less than 180 mg/dl 2 hrs.After meal.The customer is using true metrix pro meter and true metrix pro test strips.The customer feels well and did not report any symptoms.Medical attention is not reported as a result of the actual blood glucose results.During the call, a back to back blood test was not performed by the customer.The product is stored according to specification in the bedroom.The test strip lot manufacturer¿s expiration date is 06/13/2024 and open vial date is two weeks ago.The meter memory was reviewed for previous test result history: (b)(6).
 
Additional Manufacturer Narrative
Sections with additional information as of 09-mar-2023: d9: device available for evaluation.H3: device evaluated by manufacturer.H6: updated fda¿s type, findings and conclusions codes.H10: meter was returned for evaluation.Product testing was performed and no defect found.Test strips were not returned for evaluation - customer had returned the incorrect test strips.Retention testing was performed using test strips from the same lot.Retention strip lot tested within specifications.Most likely underlying root cause: mlc-062: user had poor technique.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUE METRIX PRO
Common Device Name
SYSTEM, TEST BLOOD GLUCOSE, OVER THE COUNTER
Manufacturer (Section D)
TRIVIDIA HEALTH INC
2400 nw 55th court
fort lauderdale FL 33309
Manufacturer Contact
karen devincent
2400 nw 55th court
fort lauderdale, FL 33309
MDR Report Key16368137
Report Number1000113657-2023-00075
Device Sequence Number7370107
Product Code NBW
UDI-Device Identifier00021292007867
UDI-Public(01)00021292007867
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
K140100
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date06/13/2024
Device Model NumberSTRIP, TRUE METRIX PRO50CT MG/DL
Device Lot NumberZA5035S
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Distributor Facility Aware Date01/17/2023
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/17/2023
Supplement Date Received by Manufacturer02/21/2023
Initial Report FDA Received Date02/13/2023
Supplement Report FDA Received Date03/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-